Ident. | Authors (with country if any) | Title |
---|
000236 (2017) |
Lassane Koala [Burkina Faso] ; Achille Nikiema [Burkina Faso] ; Rory J. Post [Royaume-Uni] ; Alain Brice Paré [Burkina Faso] ; Claude Montant Kafando [Burkina Faso] ; François Drabo [Burkina Faso] ; Soungalo Traoré [Burkina Faso] | Recrudescence of onchocerciasis in the Comoé valley in Southwest Burkina Faso. |
000549 (2017) |
Hugues C. Nana-Djeunga [Cameroun] ; Magellan Tchouakui [Cameroun] ; Guy R. Njitchouang [Cameroun] ; Jules B. Tchatchueng-Mbougua [Cameroun] ; Philippe Nwane [Cameroun] ; André Domche [Cameroun] ; Jean Bopda [Cameroun] ; Stève Mbickmen-Tchana [Cameroun] ; Julie Akame [Cameroun] ; Ann Tarini [Cameroun] ; Emilienne Epée [Cameroun] ; Benjamin D. Biholong [Cameroun] ; Yaobi Zhang [Sénégal] ; Jean J. Tougoue [États-Unis] ; Achille Kabore [États-Unis] ; Flobert Njiokou [Cameroun] ; Joseph Kamgno [Cameroun] | First evidence of lymphatic filariasis transmission interruption in Cameroon: Progress towards elimination |
000619 (2017) |
Sébastien D S. Pion [France] ; Cédric B. Chesnais [France] ; Gary J. Weil [États-Unis] ; Peter U. Fischer [États-Unis] ; François Missamou [République du Congo] ; Michel Boussinesq [République du Congo] | Effect of 3 years of biannual mass drug administration with albendazole on lymphatic filariasis and soil-transmitted helminth infections: a community-based study in Republic of the Congo. |
000788 (2017) |
Dziedzom Komi De Souza [Ghana] ; Irene Offei Owusu [Ghana] ; Joseph Otchere [Ghana] ; Michelle Adimazoya [Ghana] ; Kwadwo Frempong [Ghana] ; Collins Stephen Ahorlu [Ghana] ; Daniel Adjei Boakye [Ghana] ; Michael David Wilson [Ghana] | An evaluation of Wb123 antibody elisa in individuals treated with ivermectin and albendazole, and implementation challenges in Africa. |
000A47 (2016) |
Denise Mupfasoni [Suisse] ; Antonio Montresor [Suisse] ; Alexei Mikhailov [Suisse] ; Jonathan King [Suisse] | The Impact of Lymphatic Filariasis Mass Drug Administration Scaling Down on Soil-Transmitted Helminth Control in School-Age Children. Present Situation and Expected Impact from 2016 to 2020. |
000C53 (2016) |
Inge Kroidl [Allemagne, Tanzanie] ; Elmar Saathof [Allemagne] ; Lucas Maganga [Tanzanie] ; Petra Clowes [Allemagne, Tanzanie] ; Leonard Maboko [Tanzanie] ; Achim Hoerauf [Allemagne] ; Williams H. Makunde [Tanzanie] ; Antelmo Haule [Tanzanie] ; Prisca Mviombo [Tanzanie] ; Bettina Pitter [Allemagne, Tanzanie] ; Neema Mgeni [Tanzanie] ; Joseph Mabuye [Tanzanie] ; Dickens Kowuor [Tanzanie] ; Upendo Mwingira [Tanzanie] ; Mwelecele N. Malecela [Tanzanie] ; Thomas Löscher [Allemagne] ; Michael Hoelscher [Allemagne, Tanzanie] | Prevalence of Lymphatic Filariasis and Treatment Effectiveness of Albendazole/ Ivermectin in Individuals with HIV Co-infection in Southwest-Tanzania |
001099 (2016) |
Nana O. Wilson [États-Unis] ; Alioune Badara Ly [Sénégal] ; Vitaliano A. Cama [États-Unis] ; Paul T. Cantey [États-Unis] ; Daniel Cohn [États-Unis] ; Lamine Diawara [Sénégal] ; Abdel Direny [Haïti] ; Mawo Fall [Sénégal] ; Karla R. Feeser [États-Unis] ; Leanne M. Fox [États-Unis] ; Achille Kabore [États-Unis] ; Amadou F. Seck [Sénégal] ; Ngayo Sy [Sénégal] ; Daouda Ndiaye [Sénégal] ; Christine Dubray [États-Unis] | Evaluation of Lymphatic Filariasis and Onchocerciasis in Three Senegalese Districts Treated for Onchocerciasis with Ivermectin. |
001123 (2016) |
Edward K. Thomsen [Papouasie-Nouvelle-Guinée] ; Nelly Sanuku [Papouasie-Nouvelle-Guinée] ; Manasseh Baea [Papouasie-Nouvelle-Guinée] ; Samson Satofan [Papouasie-Nouvelle-Guinée] ; Elit Maki [Papouasie-Nouvelle-Guinée] ; Bart Lombore [Papouasie-Nouvelle-Guinée] ; Mark S. Schmidt [États-Unis] ; Peter M. Siba [Papouasie-Nouvelle-Guinée] ; Gary J. Weil [États-Unis] ; James W. Kazura [États-Unis] ; Lawrence L. Fleckenstein [États-Unis] ; Christopher L. King [États-Unis] | Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis. |
001410 (2016) |
Vikas Kushwaha [Inde] ; Kirti Saxena [Inde] ; Richa Verma [Inde] ; Shiv K. Verma [Inde, États-Unis] ; Deepali Katoch ; Neeraj Kumar ; Brij Lal ; P. Kalpana Murthy [Inde] ; Bikram Singh | Antifilarial activity of diterpenoids from Taxodium distichum |
001457 (2016) |
Philip J. Budge [États-Unis] ; Edmond Sognikin [Togo] ; Amanda Akosa [États-Unis] ; Els M. Mathieu [États-Unis] ; Michael Deming [États-Unis] | Accuracy of Coverage Survey Recall following an Integrated Mass Drug Administration for Lymphatic Filariasis, Schistosomiasis, and Soil-Transmitted Helminthiasis |
001583 (2015) |
A M Dorkenoo [France] ; Y K Sodahlon ; R N Bronzan ; K. Yakpa ; E. Sossou ; A. Ouro-Medeli ; M. Teko ; A. Seim ; E. Mathieu | [Lymphatic filariasis transmission assessment survey in schools three years after stopping mass drug treatment with albendazole and ivermectin in the 7 endemic districts in Togo]. |
001674 (2015) |
Fred Aboagye-Antwi [Ghana] ; Bethel Kwansa-Bentum [Ghana] ; Samuel K. Dadzie [Ghana] ; Collins K. Ahorlu [Ghana] ; Maxwell A. Appawu [Ghana] ; John Gyapong [Ghana] ; Michael David Wilson [Ghana] ; Daniel Adjei Boakye [Ghana] | Transmission indices and microfilariae prevalence in human population prior to mass drug administration with ivermectin and albendazole in the Gomoa District of Ghana |
001751 (2015) |
Yaya I. Coulibaly ; Benoit Dembele ; Abdallah Amadou Diallo ; Siaka Konaté ; Houseini Dolo ; Siaka Yamoussa Coulibaly ; Salif Seriba Doumbia ; Lamine Soumaoro ; Michel Emmanuel Coulibaly ; Moses J. Bockarie ; David Molyneux ; Thomas B. Nutman ; Amy D. Klion ; Yeya T. Toure ; Sekou F. Traore | The Impact of Six Annual Rounds of Mass Drug Administration on Wuchereria bancrofti Infections in Humans and in Mosquitoes in Mali |
001893 (2015) |
Christina A. Bulman [États-Unis] ; Chelsea M. Bidlow [États-Unis] ; Sara Lustigman [États-Unis] ; Fidelis Cho-Ngwa [Cameroun] ; David Williams [États-Unis] ; Alberto A. Rasc N Jr [États-Unis] ; Nancy Tricoche [États-Unis] ; Moses Samje [Cameroun] ; Aaron Bell [États-Unis] ; Brian Suzuki [États-Unis] ; K. C. Lim [États-Unis] ; Nonglak Supakorndej [États-Unis] ; Prasit Supakorndej [États-Unis] ; Alan R. Wolfe [États-Unis] ; Giselle M. Knudsen [États-Unis] ; Steven Chen [États-Unis] ; Chris Wilson [États-Unis] ; Kean-Hooi Ang [États-Unis] ; Michelle Arkin [États-Unis] ; Jiri Gut [États-Unis] ; Chris Franklin [États-Unis] ; Chris Marcellino [États-Unis] ; James H. Mckerrow [États-Unis] ; Anjan Debnath [États-Unis] ; Judy A. Sakanari [États-Unis] | Repurposing Auranofin as a Lead Candidate for Treatment of Lymphatic Filariasis and Onchocerciasis |
001971 (2015) |
Tekola Endeshaw [Éthiopie] ; Aseged Taye [Éthiopie] ; Zerihun Tadesse [Éthiopie] ; Moses N. Katabarwa [États-Unis] ; Oumer Shafi [Éthiopie] ; Tewodros Seid [Éthiopie] ; Frank O. Richards [États-Unis] | Presence of Wuchereria bancrofti microfilaremia despite 7 years of annual ivermectin monotherapy mass drug administration for onchocerciasis control: a study in north-west Ethiopia |
001A31 (2015) |
Darin S. Evans [États-Unis] ; Thomas R. Unnasch [États-Unis] ; Frank O. Richards [États-Unis] | Onchocerciasis and lymphatic filariasis elimination in Africa: it's about time. |
002503 (2014) |
Darin S. Evans [États-Unis] ; Kal Alphonsus [Nigeria] ; Jon Umaru [Nigeria] ; Abel Eigege [Nigeria] ; Emmanuel Miri [Nigeria] ; Hayward Mafuyai [Nigeria] ; Carlos Gonzales-Peralta [États-Unis] ; William Adamani [Nigeria] ; Elias Pede [Nigeria] ; Christopher Umbugadu [Nigeria] ; Yisa Saka [Nigeria] ; Bridget Okoeguale [Nigeria] ; Frank O. Richards [États-Unis] | Status of Onchocerciasis Transmission after More Than a Decade of Mass Drug Administration for Onchocerciasis and Lymphatic Filariasis Elimination in Central Nigeria: Challenges in Coordinating the Stop MDA Decision |
002838 (2014) |
| Meeting of the International Task Force for Disease Eradication, January 2014. |
002939 (2014) |
Mark S. Schmidt [États-Unis] ; Christopher L. King [États-Unis] ; Edward K. Thomsen [Royaume-Uni] ; Peter M. Siba [Papouasie-Nouvelle-Guinée] ; Nelly Sanuku [Papouasie-Nouvelle-Guinée] ; Lawrence Fleckenstein [États-Unis] | Liquid chromatography-mass spectrometry analysis of diethylcarbamazine in human plasma for clinical pharmacokinetic studies. |
002A92 (2014) |
William J. Kisoka [Tanzanie] ; Paul E. Simonsen [Danemark] ; Mwelecele N. Malecela [Tanzanie] ; Britt P. Tersb L [Danemark] ; Declare L. Mushi [Tanzanie] ; Dan W. Meyrowitsch [Danemark] | Factors Influencing Drug Uptake during Mass Drug Administration for Control of Lymphatic Filariasis in Rural and Urban Tanzania |
002E61 (2014) |
Brittany A. Eddy ; Anna J. Blackstock ; John M. Williamson ; David G. Addiss ; Thomas G. Streit ; Valery M. Beau De Rochars ; Leanne M. Fox | A Longitudinal Analysis of the Effect of Mass Drug Administration on Acute Inflammatory Episodes and Disease Progression in Lymphedema Patients in Léogane, Haiti |